Search
Harbinger Health’s Steve Hahn on the science of early cancer Dx after raising a $140M Series B
Steve Hahn describes how Harbinger Health is trying to catch the earliest signals of cancer, and how this information might be used.
Sep 28, 2023
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.
bottom of page